GlaxoSmithKline Consumer Nigeria Plc reported its 2023 second-quarter results showing pre-tax profits grew by 18.14% year on year, reaching N274 ...
GlaxoSmithKline Consumer Nigeria Plc, a leading research-based pharmaceutical and healthcare company, has declared a dividend of N538.14 million for the ...
The company’s annual turnover increased from N18.41 billion in 2018 to N20.76 billion in 2019.
GlaxoSmithKline Consumer Nigeria Plc on 24th July 2020, will pay dividends electronically to Shareholders whose names appear in the Register.
GlaxoSmithKline Consumer Nigeria Plc, led the losers chart in today's trades on the floor of the Nigerian Stock Exchange (NSE).
The Board of Directors of GlaxoSmithKline Consumer Nigeria Plc (GSK), has appointed a new Managing Director (MD).
GlaxoSmithKline Consumer Nigeria Plc's board of directors has disclosed the resignation of Bhushan Akshikar, the Managing Director of the Company and ...
Following the earlier announcement on the restructuring of its supply chain operating model, the board of GSK Consumer Nigeria Plc ...
Corporate actions are decisions taken by companies’ boards of directors or management teams, that could have impacts on the firms ...
GlaxoSmithKline Consumer Nigeria Plc welcome directors.
